Cardurion Pharmaceuticals
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Cardurion Pharmaceuticals sits in the top decile of US sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count).
Cardurion Pharmaceuticals: 9 sponsored US clinical trials, 1 recruiting.
Cardurion Pharmaceuticals sponsors 9 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 5 completed. 0 of these trials are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Catecholaminergic Polymorphic Ventricular Tachycardia, with 1 trials.
Top-decile sponsor footprint
Cardurion Pharmaceuticals ranks in the top decile of sponsors by registered trial count (#1,458 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Open and recent trials
9 total, page 1 of 1
A Phase 2 Study of CRD-4730 in CPVT
NCT06658899
Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Preserved Ejection Fraction (Cycle-2-PEF)
NCT06215586
A Study to Assess Safety & Effectiveness of Tovinontrine in Chronic Heart Failure With Reduced Ejection Fraction (Cycle-1-REF)
NCT06215911
Effectiveness of CRD-4730 in Participants With Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)
NCT06005428
Effect of Coadministration of Itraconazole on the Pharmacokinetics of CRD-740
NCT05437094
Effectiveness of CRD-740 in Heart Failure
NCT05409183
A Study of IMR-687 in Subjects With Sickle Cell Disease
NCT04474314
A Study of IMR-687 in Adult Participants With Sickle Cell Anemia (Homozygous HbSS or Sickle-β0 Thalassemia)
NCT03401112
A Study of IMR-687 in Healthy Adult Volunteers
NCT02998450
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 7 |
Therapeutic Areas
What is open in the Cardurion Pharmaceuticals pipeline
1 recruiting of 9 indexed (11% open); 5 completed (56%).
Phase mix: 0 late (III/IV) vs 9 early (I/II) (early-phase heavy).
Top condition: Catecholaminergic Polymorphic Ventricular Tachycardia (1 trial), 0 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Cardurion Pharmaceuticals: open-pipeline peers nationwide
Peers matched on 9 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
Cardurion Pharmaceuticals sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 9 trials (± recruiting share)
- 4D Molecular Therapeutics · 9 trials · 44% recruiting
- 9 Meters Biopharma · 9 trials · 0% recruiting
- Aadi Bioscience · 9 trials · 33% recruiting
- Ablynx, a Sanofi company · 9 trials · 0% recruiting
Sponsors near 11% open enrollment (± trial volume)
- ADC Therapeutics S.A. · 11% recruiting · 18 trials
- Adrian Vella · 11% recruiting · 9 trials
- AIDS Malignancy Consortium · 11% recruiting · 45 trials
- Amylyx Pharmaceuticals · 11% recruiting · 9 trials
Related
What to do with this Cardurion Pharmaceuticals page
9 registered trials is a research-attention snapshot, not an endorsement of Cardurion Pharmaceuticals or any single study.
- 1 of Cardurion Pharmaceuticals's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Catecholaminergic Polymorphic Ventricular Tachycardia is the condition Cardurion Pharmaceuticals studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Catecholaminergic Polymorphic Ventricular Tachycardia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Cardurion Pharmaceuticals pipeline card: 9 registered trials from official public datasets.Report a data error.